Search Browse Earnings

Armata Pharmaceuticals, Inc. — SlamSEC

Armata Pharmaceuticals, Inc.

NYSE:ARMP

Biological Products, (No Diagnostic Substances)·LOS ANGELES, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$39.9M

FY 2024

Net Income

-$69.0M

FY 2024

EPS (Diluted)

-$1.91

FY 2024

Stock Price

$11.50

-3.8%

2026-03-11

52W Range

$0.90 – $16.34

P/E Ratio

-6.0x

Market Cap

$417.8M

Cash

$13.5M

FY 2024

Total Debt

$803,000

FY 2017

Net Cash

$12.7M

FY 2017

Enterprise Value

$405.1M

Debt / EBITDA

0.3x

FY 2024

EV / EBITDA

-10.1x

Employees

—

CEO

Birx Deborah